Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantrone

Br J Haematol. 2021 Jan;192(2):e60-e63. doi: 10.1111/bjh.17220. Epub 2020 Nov 21.

Affiliations

¹ Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
² Department of Obstetrics and Fetal Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
³ Division of Neonatology and Paediatric Intensive Care, University Children's Hospital, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

PMID: 33222152
DOI: 10.1111/bjh.17220

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
Bridged Bicyclo Compounds, Heterocyclic / therapeutic use*
Cytarabine / administration & dosage
Cytarabine / therapeutic use*
Female
Humans
Leukemia, Myeloid, Acute / drug therapy*
Mitoxantrone / administration & dosage
Mitoxantrone / therapeutic use*
Pregnancy
Pregnancy Complications, Neoplastic / drug therapy*
Sulfonamides / administration & dosage
Sulfonamides / therapeutic use*

Substances

Bridged Bicyclo Compounds, Heterocyclic
Sulfonamides
Cytarabine
Mitoxantrone
venetoclax